HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
ANGO
Angiodynamic Inc
Healthcare Medical Instruments & Supplies · New York, USA · Reports in usd
—
Market Cap: $642.1M
Market Cap
$642.1M
Enterprise Val
$588.2M
P/E Ratio
-17.48
P/B Ratio
3.76
Trailing PEG (1Y)
-0.22
As Of
Sep 27, 2026

Overview & Key Metrics

Reporting period: May 31, 2026 · Q4 2026
Book Value$170.8M
Gross Margin54.01%
Profit Margin54.01%
Return on Equity-21.01%
Return on Assets-13.82%
Current Ratio2.19
Debt/Equity0.00
LT Debt/Equity0.00
Revenue Per Share2.10

Income Statement

May 31, 2026
Revenue$86.6M
Cost of Revenue$39.8M
Gross Profit$46.8M
R&D$8.2M
SG&A$41.4M
Operating Expenses$53.0M
Operating Income-$6.3M
Interest Expense$105.0K
Tax Expense$370.0K
Net Income-$11.4M
EPS (Basic)$-0.27
EPS (Diluted)$-0.27
EBIT-$10.9M
EBITDA-$5.0M
Consolidated Income-$11.4M
Non-Controlling Interests$0.00

Balance Sheet

May 31, 2026
Cash & Equivalents$53.9M
Accounts Receivable$48.3M
Inventory$52.4M
Current Assets$163.4M
LT Investments$0.00
Property, Plant & Equipment$27.1M
Intangibles$67.2M
Non-Current Assets$103.8M
Total Assets$267.2M
Accounts Payable$31.5M
Current Debt$0.00
Current Liabilities$74.7M
LT Debt$0.00
Non-Current Liabilities$21.6M
Total Liabilities$96.3M
Total Debt$0.00
Retained Earnings-$465.9M
Shareholder Equity$170.8M
Shares Outstanding41,318,915

Cash Flow Statement

May 31, 2026
Operating Cash Flow$17.5M
Investing Cash Flow-$1.3M
Financing Cash Flow-$108.0K
CapEx-$1.3M
Free Cash Flow$16.2M
Depreciation & Amort.$6.0M
Stock-Based Comp$3.9M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$97.0K
Equity Issued/Repaid-$11.0K
Dividends Paid$0.00
Net Change in Cash$16.1M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h